CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS

Lobbying for NOVARTIS · Bio-pharmaceutical company

Filing 4th Quarter - Report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 16, 2026

Income

$50,000.00

What the client paid this registrant for the period.

Client based in

District of Columbia

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 1

Lobbying activity 2

Health Issues

Support for: H.R. 1672 - Maintaining Investments in New Innovation Act (MINI Act)

Medicare/Medicaid

Issues related to the pharmaceutical industry

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.